In breast cancer, expression of the TROP-2 gene has been identified across all subtypes, with particularly elevated levels observed in HR+ HER2-negative and triple-negative breast cancer (TNBC) compared to HER2-positive disease (21). This evidence concerns the gene ERBB2 and breast carcinoma.